P21 gene variation and late-onset Alzheimer's disease in the Italian population

Dement Geriatr Cogn Disord. 2013;35(1-2):51-7. doi: 10.1159/000345788. Epub 2013 Jan 9.

Abstract

Background: Variation at the cyclin-dependent kinase inhibitor gene P21 in a patient sample of the Italian population was investigated in search of genetic factors potentially involved in sporadic late-onset Alzheimer's disease (AD).

Methods: Two single nucleotide polymorphisms (SNPs) were studied in this gene: a C>A transversion at codon 31 (ser>arg) in exon 2 (RS1801270) and a C>T transition occurring 20 bp downstream from the stop codon of exon 3 (RS1059234).

Results: The odd ratios were: RS1801270 A allele = 0.62 (95% CI = 0.33-1.18; p = 0.14); RS1059234 T allele = 0.57 (95% CI = 0.33-0.98; p = 0.04). In addition, a longer duration of disease was found with genotypes carrying the RS1059234 T allele (4.3 ± 2.5 years) than with those not carrying it (3.3 ± 2.1 years) (p = 0.001).

Conclusion: In the present sample, one of the two SNPs seems in some way related to AD, since carriers of one allele were slightly protected against AD onset.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / physiopathology*
  • Analysis of Variance
  • Codon
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics*
  • Cyclin-Dependent Kinase Inhibitor p21 / physiology*
  • DNA / genetics
  • Data Interpretation, Statistical
  • Exons / genetics
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Polymorphism, Single Nucleotide / genetics

Substances

  • Codon
  • Cyclin-Dependent Kinase Inhibitor p21
  • DNA